These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9108528)

  • 21. Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system.
    Cacciatore JJ; Chasin LA; Leonard EF
    Biotechnol Adv; 2010; 28(6):673-81. PubMed ID: 20416368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient and inducible expression of vaccinia/T7 recombinant viruses.
    Mohamed MR; Niles EG
    Methods Mol Biol; 2004; 269():41-50. PubMed ID: 15114006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A baculovirus expression vector system for simultaneous protein expression in insect and mammalian cells.
    Philipps B; Forstner M; Mayr LM
    Biotechnol Prog; 2005; 21(3):708-11. PubMed ID: 15932246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of high-recombinant- protein-producing Chinese hamster ovary (CHO) cells.
    Goergen JL; Monaco L
    Methods Mol Biol; 2004; 267():477-83. PubMed ID: 15269444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
    Mitta B; Weber CC; Rimann M; Fussenegger M
    Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant expression of proteoglycans in mammalian cells. Utility and advantages of the vaccinia virus/T7 bacteriophage hybrid expression system.
    McQuillan DJ; Seo NS; Hocking AM; McQuillan CI
    Methods Mol Biol; 2001; 171():201-19. PubMed ID: 11450231
    [No Abstract]   [Full Text] [Related]  

  • 27. Design of retroviral expression vectors.
    Comstock KE; Watson NF; Olsen JC
    Methods Mol Biol; 1997; 62():207-22. PubMed ID: 9108523
    [No Abstract]   [Full Text] [Related]  

  • 28. Construction of engineered CHO strains for high-level production of recombinant proteins.
    Kito M; Itami S; Fukano Y; Yamana K; Shibui T
    Appl Microbiol Biotechnol; 2002 Dec; 60(4):442-8. PubMed ID: 12466885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baculovirus ETL promoter acts as a shuttle promoter between insect cells and mammalian cells.
    Liu YK; Chu CC; Wu TY
    Acta Pharmacol Sin; 2006 Mar; 27(3):321-7. PubMed ID: 16490168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding.
    Hu YC; Tsai CT; Chang YJ; Huang JH
    Biotechnol Prog; 2003; 19(2):373-9. PubMed ID: 12675574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of hepatitis C viral structure protein by recombinant vaccinia virus].
    Wang X; Tan W; Cong X; Guo K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):340-3. PubMed ID: 15617243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using matrix attachment regions to improve recombinant protein production.
    Harraghy N; Buceta M; Regamey A; Girod PA; Mermod N
    Methods Mol Biol; 2012; 801():93-110. PubMed ID: 21987249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward higher order control modalities in mammalian cells-independent adjustment of two different gene activities.
    Fux C; Fussenegger M
    Biotechnol Prog; 2003; 19(1):109-20. PubMed ID: 12573013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level expression of full-length antibodies using trans-complementing expression vectors.
    Bianchi AA; McGrew JT
    Biotechnol Bioeng; 2003 Nov; 84(4):439-44. PubMed ID: 14574701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and isolation of recombinant MVA.
    Staib C; Drexler I; Sutter G
    Methods Mol Biol; 2004; 269():77-100. PubMed ID: 15114009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of vaccinia virus as an infectious molecular cloning and expression vector.
    Moss B; Smith GL; Mackett M
    Gene Amplif Anal; 1983; 3():201-13. PubMed ID: 6101027
    [No Abstract]   [Full Text] [Related]  

  • 39. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
    Ferrer MF; Zanetti FA; Calamante G
    Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of site-specific integration system to high-level expression recombinant proteins in CHO cells].
    Zhou H; Liu ZG; Sun ZW; Yu WY
    Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):756-62. PubMed ID: 17822058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.